Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 503 of 1,261

  1. US 10272034

    Auris formulations for treating otic diseases and conditions

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  2. US 10272039

    Topical sodium nitrite formulation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  3. US 10272046

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  4. CA 3079172

    COMPOSITIONS ET METHODES POUR L'EDITION GENIQUE POUR L'HEMOPHILIE A

    CRISPR THERAPEUTICS AG [CH] · Granted Apr 25, 2019 · Expires Apr 20, 2039

    granted

  5. US 10265282

    Cancer treatment

    VANDA PHARMACEUTICALS INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  6. US 10267786

    Systems and methods for high-resolution imaging

    The Board of Regents of the University of Texas System · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  7. US 10266549

    ULK1 inhibitors and methods using same

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  8. US 10266496

    Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  9. US 10265410

    Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects

    HALOZYME, INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  10. US 10265397

    Formulation for photodynamic therapy

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  11. US 10265387

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  12. US 10265375

    Ophthalmic compositions

    AURINIA PHARMACEUTICALS INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  13. US 10265368

    Date pit composition for the treatment of animals

    UNITED ARAB EMIRATES UNIVERSITY · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  14. US 10265382

    Complexes of IL-15 and IL-15Ralpha and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  15. US 10265329

    Altering steroid metabolism for treatment of steroid-dependent disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  16. US 10265313

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  17. US 10265300

    Methods of treating seizure disorders

    OVID THERAPEUTICS INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  18. US 10265372

    Molecular composition for enhancing and rejuvenating maintenance and repair of mammalian tissues

    The Regents of the University of California · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  19. US 10265324

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  20. US 10265400

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  21. US 10265338

    Compounds and methods for treating neurological and cardiovascular conditions

    The Board of Regents of the University of Texas System · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  22. US 10265275

    Phenolic coatings and methods of making and using same

    Northwestern University · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  23. US 10265377

    Methods and compositions for treating Huntington's Disease

    Sangamo Therapeutics, Inc. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  24. US 10266850

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.